Current Challenges in Digital Representation of Variation in Cancer Care.

artificial intelligence data visualisation design digital health machine learning

Journal

Studies in health technology and informatics
ISSN: 1879-8365
Titre abrégé: Stud Health Technol Inform
Pays: Netherlands
ID NLM: 9214582

Informations de publication

Date de publication:
24 Sep 2024
Historique:
medline: 25 9 2024
pubmed: 25 9 2024
entrez: 25 9 2024
Statut: ppublish

Résumé

Advances in cancer treatment have improved patient outcomes and survival in recent decades. Increased complexity, duration, and individualisation of treatment protocols present an important challenge for care teams monitoring adherence to best-practice care. A rigid rules-based system for flagging outliers is not fit for purpose, as there are sound reasons for deviating from baseline protocols, such as the management of treatment side effects to a tolerable degree, however the methods for determining the bounds of appropriateness for variation are not well studied or understood. The development of digital representations to inform cancer care delivery in a timely and continuing manner is crucial. This scoping review seeks to identify gaps in current methods and propose a novel approach to digitally represent patient journeys in clinically meaningful visual and computational forms. These methods can be combined to produce real-time, clinically applicable tools such as group-level business-intelligence dashboards (are processes and resources adequate to ensure that patients are being treated according to best practice?) as well as individual-level decision support (what is the likely outcome for this patient if treatment is stopped early based on prior data?) and day to day clinical workflows (what has happened to this patient so far?).

Identifiants

pubmed: 39320182
pii: SHTI240892
doi: 10.3233/SHTI240892
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

60-65

Auteurs

Sophia Kee (S)

CBDRH, University of New South Wales, Australia.

Ivy Cerelia Valerie (IC)

CBDRH, University of New South Wales, Australia.

Georgina Kennedy (G)

Maridulu Budyari Gumal (SPHERE) Cancer Clinical Academic Group, Australia.
South Western Sydney Clinical School, University of NSW, Australia.
Ingham Institute for Applied Medical Research, Australia.

Merran Findlay (M)

Maridulu Budyari Gumal (SPHERE) Cancer Clinical Academic Group, Australia.
Cancer Services, Royal Prince Alfred Hospital, Sydney Local Health District, Australia.
Chris O'Brien Lifehouse, Australia.
Cancer Care Research Centre, University of Sydney, Australia.
The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council, Australia.

Timothy Churches (T)

Ingham Institute for Applied Medical Research, Australia.
UNSW Sydney School of Clinical Medicine, Australia.

Alexandra Vassar (A)

UNSW Sydney School of Computer Science and Engineering, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH